SEC Form 4 · accession 0001102948-15-000001
INTEGRATED BIOPHARMA INC · INBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carl Desantis
Director · 10% Owner
Period of report
Jun 2, 2015
Accepted (ET)
Jun 3, 2015 · 7:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016504
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTION (RIGHT TO BUY)F1 | $0.10 | Jun 2, 2015 | A | 50,000 | A | — | Jun 2, 2025 | COMMON STOCK | 50,000 | 50,000 | D |
Explanation of responses
- F1(1) The option vests 75% (37,500) on grant date (June 2, 2015) and in twelve monthly installments for the remaining 25% (12,500) beginning on July 2, 2015.